Clinical trial Recruiting at 10 sites Interventional Ages 18 to 45 Women only

Alcohol sclerotherapy for pelvic pain and quality of life in ovarian endometrioma

Official title: Effect of US-guided Alcohol Sclerotherapy for Endometriomas on Pelvic Pain and Quality of Life

Run by Hospital Universitari de Bellvitge · NCT06955221 · Data updated 2026-11-12

This trial will try ultrasound-guided alcohol sclerotherapy to see if it reduces pelvic pain and improves quality of life in women aged 18–45 with ovarian endometriomas compared with expectant management.

More Pelvic Pain trials

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexWomen only
Enrollment288 (estimated)
SponsorHospital Universitari de Bellvitge
Academic / other
Locations26 sites (Palma de Mallorca, Balearic Islands and 25 other locations)
StatusRecruiting
StartedJanuary 1, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2027
Registry record updatedNovember 10, 2026
Trial IDNCT06955221 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 18–45 with ultrasound-suspected unilocular (or thin-septum) ovarian endometriomas 30–100 mm in size, CA125 ≤300 UI/mL and HE4 ≤70 pM, not pregnant and willing to give informed consent.

Probably not a fit

Patients with very small (<30 mm) or very large (>100 mm) cysts, ultrasound signs suggesting dermoid or high malignancy risk, those requiring surgical treatment for severe extra-ovarian disease, pregnant women, or those with prior ovarian/uterine cancer are unlikely to benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Women meeting entry criteria are randomly assigned to receive ultrasound-guided aspiration with alcohol sclerotherapy or to expectant management, with outcomes compared at six months. Pain and quality of life are measured using standardized instruments including the EHP-5, and blood and urine samples are collected for biomarkers such as cortisol, IL-6, and hsCRP. The intervention is a minimally invasive outpatient procedure performed under ultrasound guidance, and the control arm receives routine monitoring without immediate intervention. The trial focuses on unilocular or thin-septum endometriomas sized 30–100 mm and excludes cases with suspicion of malignancy or indications for immediate surgery.

Why it matters

Potential benefit: If successful, the procedure could reduce pelvic pain and improve quality of life while avoiding or delaying surgery and preserving ovarian tissue.

How similar studies have gone: Smaller series and nonrandomized reports have shown symptom relief and cyst reduction after alcohol sclerotherapy, but high-quality randomized data remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female sex
* Age ≥18 and ≤45 years
* Ultrasound suspicion of unilocular endometrioma or with a thin septum less than 3 mm
* Size between 30-100 mm, persistent for at least 3-6 months since diagnosis
* Ca125 marker \<300 UI/mL and HE4 \< 70 pM
* Signed informed consent

Exclusion Criteria:

* Age \<18 or \>45 years
* History of ovarian or uterine cancer
* Endometrioma size \<30 mm or \>100 mm
* Indication for surgical treatment of the endometrioma due to suspected severe extra-ovarian endometriosis or any other cause
* Ultrasound suspicion of dermoid cysts, anechoic cysts, or cysts with high risk of malignancy
* Ca125 \>300 UI/mL
* HE4 \>70 pM
* Pregnant women
* Patients who do not wish to participate in the study or who are mentally incapacitated

Where it's running

  • Consorci Sanitari de l'Anoia
    Igualada, Barcelona, Spain
    Recruiting
  • Consorci Sanitari Integral
    L'Hospitalet de Llobregat, Barcelona, Spain
    Recruiting
  • Hospital Universitario de Bellvitge
    L'Hospitalet de Llobregat, Barcelona, Spain
    Recruiting
  • Hospital de Viladecans
    Viladecans, Barcelona, Spain
    Recruiting
  • Hospital General Universitario Los Arcos del Mar Menor
    San Javier, Murcia, Spain
    Recruiting
  • Hospital del Mar
    Barcelona, Spain
    Recruiting
Show 20 more locations
  • Hospital Universitario Ramón y Cajal
    Madrid, Spain
    Recruiting
  • Hospital Clínico San Carlos
    Madrid, Spain
    Recruiting
  • Hospital Universitario 12 de Octubre
    Madrid, Spain
    Recruiting
  • Hospital Recoletas Salud Campo Grande
    Valladolid, Spain
    Recruiting
  • Hospital Universitario Son Espases
    Palma de Mallorca, Balearic Islands, Spain
    Not yet recruiting
  • Hospital Universitario Germans Trias i Pujol
    Badalona, Barcelona, Spain
    Not yet recruiting
  • Hospital San Juan de Dios de Martorell
    Martorell, Barcelona, Spain
    Not yet recruiting
  • Consorci Corporació Sanitària Parc Taulí
    Sabadell, Barcelona, Spain
    Not yet recruiting
  • Parc Sanitari Sant Joan de Deu
    Sant Boi de Llobregat, Barcelona, Spain
    Not yet recruiting
  • Hospital Universitario San Pedro
    Logroño, La Rioja, Spain
    Not yet recruiting
  • Hospital de la Vega Lorenzo Guirao
    Cieza, Murcia, Spain
    Not yet recruiting
  • Hospital Universitario de Canarias
    San Cristóbal de La Laguna, Santa Cruz De Tenerife, Spain
    Not yet recruiting
  • Hospital Universitari Sant Joan de Reus
    Reus, Tarragona, Spain
    Not yet recruiting
  • Clínica Sanabria
    Granada, Spain
    Not yet recruiting
  • Hospital Universitario de Jaén
    Jaén, Spain
    Not yet recruiting
  • Hospital Universitario Arnau de Vilanova
    Lleida, Spain
    Not yet recruiting
  • Hospital Universitario Joan XXIII
    Tarragona, Spain
    Not yet recruiting
  • Consorcio Hospital General Universitario de València
    Valencia, Spain
    Not yet recruiting
  • Hospital Clínico Universitario Lozano Blesa
    Zaragoza, Spain
    Not yet recruiting
  • Hospital Universitario de Álava - Txagorritxu
    Vitoria-Gasteiz, Álava, Spain
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.